Tiaoshen Tongluo Attenuates Fibrosis by Modulating the TGF-β1/Smad Pathway in Endometrial Stromal Cells and a Rat Model of Intrauterine Adhesion

被引:13
作者
Niu, Hongping [1 ,2 ]
Miao, Xiaoling [2 ]
Zhan, Xingxiu [2 ]
Zhou, Xiaona [3 ]
Li, Xingyan [2 ]
Jiang, Lijuan [4 ]
机构
[1] Nanjing Univ Chinese Med, Dept Gynecol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[2] Yunnan Univ Chinese Med, Dept Gynecol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[3] Yunnan Univ Chinese Med, Off Grad Management, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
[4] Yunnan Univ Chinese Med, Tradit Chinese Med Hlth Serv Ctr, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
SIGNALING PATHWAY; CHINESE MEDICINE; HEPATIC-FIBROSIS; STEM-CELL; TGF-BETA; IN-VIVO; EXPRESSION; DECOCTION; INJURY; ALPHA;
D O I
10.1155/2021/6675329
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Intrauterine adhesion (IUA) is a serious complication caused by excessive fibrosis resulting from endometrial repair after trauma. The traditional Chinese medicine Tiaoshen Tongluo recipe (TTR) contains ingredients associated with the alleviation of fibrosis. The transforming growth factor-beta 1 (TGF-beta 1)/Smad pathway is thought to mediate fibrosis in IUA. In this study, we evaluated the influence of TTR on endometrial fibrosis in a rat model of IUA and in TGF-beta 1-stimulated endometrial stromal cells (ESCs). TTR was found to alleviate the level of endometrial fibrosis in a rat model of IUA. A higher number of collagen fibers and greater damage were observed in the endometrial tissue of untreated rats compared to those treated with TTR. The expression of TGF-beta 1, Smad2, Smad3, and Smad4 was upregulated following IUA, whereas Smad7 expression was downregulated. TTR lowers the expression of TGF-beta 1, Smad2, Smad3, and Smad4 but increases the expression of Smad7 in vivo, indicating that TTR can modulate the expression of the TGF-beta 1/Smad pathway to mediate fibrosis. In ESCs, the phosphorylation of Smad2 and Smad3 and upregulation of Smad4 were induced by TGF-beta 1 whereas the expression of Smad7 was inhibited. Administration of TTR reduces the phosphorylation of Smad2 and Smad3, increases Smad4 expression induced by TGF-beta 1, and promotes the expression of Smad7. TTR modulates the TGF-beta 1/Smad pathway to alleviate the generation of fibrotic tissue in response to IUA.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway
    Elsayed, Mohammed
    Moustafa, Yasser M.
    Mehanna, Eman T.
    Elrayess, Ranwa A.
    El-Sayed, Norhan M.
    Hazem, Reem M.
    LIFE SCIENCES, 2024, 337
  • [22] REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway
    Cho, Sam Seok
    Lee, Ji Hyun
    Kim, Kyu Min
    Park, Eun Young
    Ku, Sae Kwang
    Cho, Il Je
    Yang, Ji Hye
    Ki, Sung Hwan
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 176 : 246 - 256
  • [23] Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway
    Feng, Feifei
    Li, Nannan
    Cheng, Peng
    Zhang, Huanan
    Wang, Hui
    Wang, Yongbin
    Wang, Wei
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [24] HGF alleviates renal interstitial fibrosis via inhibiting the TGF-β1/SMAD pathway
    Xu, J.
    Yu, T-T
    Zhang, K.
    Li, M.
    Shi, H-J
    Meng, X-J
    Zhu, L-S
    Zhu, L-K
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7621 - 7627
  • [25] Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway
    Qu, Yubei
    Zhang, Liang
    Kang, Zechun
    Jiang, Wanglin
    Lv, Changjun
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 34 : 1 - 7
  • [26] Lipopolysaccharide enhances TGF-β1 signalling pathway and rat pancreatic fibrosis
    Sun, Li
    Xiu, Ming
    Wang, Shuhua
    Brigstock, David R.
    Li, Hongyan
    Qu, Limei
    Gao, Runping
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (04) : 2346 - 2356
  • [27] Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β-Smad3 Pathway
    Wang, Yinhui
    Yu, Kun
    Zhao, Chengcheng
    Zhou, Ling
    Cheng, Jia
    Wang, Dao Wen
    Zhao, Chunxia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
    Jin, Zhibo
    Gu, Chaohui
    Tian, Fengyan
    Jia, Zhankui
    Yang, Jinjian
    CELL AND TISSUE RESEARCH, 2017, 369 (03) : 603 - 610
  • [29] Xiaokeping Mixture Attenuates Diabetic Kidney Disease by Modulating TGF-β/Smad Pathway in db/db Mice
    Yang, Bo
    Xia, Zhongni
    Xin, Chuanwei
    Ma, Chenggang
    Zhang, Feng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [30] Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway
    Li, Zezhao
    Hong, Zhen
    Peng, Zhiqing
    Zhao, Yongcai
    Shao, Rusheng
    HUMAN CELL, 2018, 31 (03) : 199 - 209